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bridges various geographic and cultural environments, and
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research for the worldwide community.
● Exploring the inter-relationship between disease sever-
ity and prognosis promises to improve our conception and
understanding of venous problems.
● Exploration of innovative surgical and minimally inva-
sive therapy offers to decrease pain and promises equivalent
or better outcome for both refluxive and embolic venous
disorders.
● Exploration of new compounds has resulted in the
introduction of new and effective oral anticoagulants for
acute venous thrombosis.
● Descriptions of clinical findings using the internation-
ally utilized CEAP classification, its derivative scoring sys-
tems, and other functional assessments, now offer a com-
mon language and framework for communications on
chronic venous disorders.
● Understanding derives from exploration and descrip-
tion, and will inevitably improve with technological
innovation.
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these tools lead us to a better understanding of the disease
process and its effects. However, much remains to be
learned, as new knowledge often brings more questions
than answers. Ultimately, the role of the AVF is to identify
value, based upon good evidence for interventions that
make a difference to the patient, to improve the manage-
ment of patients with these diseases.
PERSONAL REFLECTIONS
Let me briefly digress to recognize that all of you, by
encouragement and critique, have stimulated and encour-
aged my interest in the problems associated with medical
science and venous disease, in particular. As is often the
case, various individuals have contributed specific legacies.
First, it is indeed fortunate that both of my parents could
attend this year’s annual meeting. They imbued values of
honesty and persistence, a desire to make a contribution by
“doing it right” in whatever I chose to do, and apparently,
bequeathed healthy genes. At an age similar to that of my
son Tom, my dad invited me to attend an American College
of Surgeons Meeting where he was presiding and his pro-
gram director, Professor Loyal Davis from Northwestern
University, was the featured guest speaker. I don’t remem-
ber much of what Dr Davis had to say but was duly
impressed that Dad and Dr Davis had “gotten it right” or
none of us would have been there. Subsequently, I have
enjoyed a professional relationship with two former presi-
dents of this organization associated with Northwestern,
Drs Bergan and Yao. Mom, who graduated with an ad-
vanced degree in music from the same institution, encour-
aged my meager musical abilities and in the process, devel-
oped the instinct to revise or practice until a job gets done
right—even though there is never enough time. My sister
Kristen has always offered a mirthful beacon of respite from
the too busy, too serious, world of academic vascular sur-
gery and will make up for my lack of participation with the
AVF tennis enthusiasts.
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February 2005356 PadbergIn no small measure, it is certain that I would not be
standing here today were it not for the loving and unselfish
support tendered by my wife Sharon. Thank you, Sharon,
for all of your sacrifices in looking after us and especially for
nurturing Tom III, who provided another chance for both
of us to participate in the activities of a modern childhood!
As a surgical intern, newly migrated from the southwest
(Arkansas) to the urbane Boston environment of New
England, I encountered a classical scholar who was then
chief resident of the Harvard Surgical Service, former Pres-
ident T.F. O’Donnell. I suspect Tom was more impressed
with my transportation than me, but he left an indelible
impression of self-confidence supported by an instantly
well-referenced encyclopedic knowledge of vascular topics.
It was real honor to have our recent work on venous
hemodynamics included in his presidential musings.
Al Persson, who arrived in Boston later than I, provided
sincere friendship and professional guidance during my
initial consideration of a career in vascular surgery. He was
responsible for sponsoring my first exposures to the na-
tional vascular society meeting and a vascular-specific post-
graduate symposium similar to the one that preceded this
meeting. In part deriving from participation in these pro-
grams, I came to know Bob Hobson, who gave me respon-
sibility for the vascular service at University Hospital,
Newark, and who continues to provide an accomplished
professional example.
A key feature of the academic section at New Jersey
Medical School was an emphasis on detailed knowledge of
clinical data as well as its source and the quality of the
information. A master of persuasion, Bob is particularly
adept at rallying his troops to make things work, especially
when the odds seem to militate against success. While he
Fig 1. The American Venous Forum, founded in 198
research for the worldwide community of physicians andencouraged us in our calf pump therapy trial, we returnedthe favor by contributing to major trials in which he served
as principal investigator (the Veterans Administration trial
for asymptomatic carotid stenosis, the Asymptomatic Ca-
rotid Atherosclerosis Study [ACAS], and the Carotid Re-
vascularization Endarterectomy Stenting Trial, [CREST]).
Our entire clinical group (Pappas, Lal, Araki, Cerveira) has
regularly contributed to this meeting.
Sincere thanks to Bob Kistner, Bob Rutherford, and Bo
Eklof for providing solid advice, experienced clinical obser-
vation, and the power of leadership by example. As the AVF
leadership makes the transition from its founders into our
new generation, we intend to ensure that the quest to
explore, describe, and understand chronic venous disease
has a promising future.
THE MISSION OF THE AMERICAN VENOUS
FORUM
“The mission of the American Venous Forum is to im-
prove the care of patients with venous and lymphatic disorders
by providing a forum dedicated to the clinical practice and
education and to the exchange of information concerning
basic and clinical research pertaining to the venous and lym-
phatic systems.” How have we, the members of the AVF
succeeded in accomplishing our goals (Fig 1)?
The annual meeting of the AVF is considered by many
to be the most important meeting of the year for those
interested in the management of patients with venous
disorders.1,2 Numerous unsolicited suggestions, full atten-
dance despite good weather, and comments on the evalu-
ation forms have reinforced the educational value of the
postgraduate course. The plenary sessions continue to offer
exchange of information in both basic and clinical science.
The modest size of our organization and the structure of
vides a platform for the exchange of clinical and basic
eons interested in the management of venous diseases.8, prothe meeting facilitate collegial interaction and frequent,
land
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guest lecturers (Table) represent a virtual Who’s Who of
those making significant contributions to the general ve-
nous knowledge base. The same can be said of the group of
surgeons (Table) who have preceded me on this podium.
The annual attendance by many of these individuals attests
to the value of this enclave for the serious study of venous
and lymphatic diseases.
The influence of the programs sponsored by the AVF in
the United States and, indeed, throughout the world has
been enormous. Witness the existence of the European
Venous Forum and proposals for other freestanding soci-
eties devoted to venous diseases now occurring throughout
the civilized world. The concept of a forum specifically for
the presentation of material on venous topics alone was
pioneered by a venous forum attached to the British Royal
Society of Medicine.3
Observing the productive response to this forum and
the several European-American Venous Symposia, a num-
ber of prominent surgeons in the United States (our
founders)4,5 petitioned the Society for Vascular Surgery
and the then joint council for support of a similar forum to
be attached to the larger society and to meet on an annual
basis. Fortunately (in retrospect), the joint council re-
sponded with the recommendation that a new organization
be established for this purpose.
“Naissance of the American Forum” was the subject of
the first AVF Presidential Address by John Bergan, which
discussed the organization of our then fledgling society.
The term naissance means new birth, and implies a national
origin; the more familiar term, renaissance, refers to a
multinational or cultural rebirth. Both concepts are encom-
passed by the role of the AVF. I am grateful to our archivist
for the opportunity to preview the discs summarizing the
conception, founding, and realization of the maturing or-
ganization we now proudly call the AVF, and hope that
each of you enjoy the enormous effort which has culmi-
Table I. Guest lecturers and presidents of the American V
Guest Lecture
1989
1990 Hugo Partsch, Austria
1991 Jack Hirsch, Canada
1992 G.W.Schmid-Schonbein, Un
1993 Olav Thulesius, Sweden
1994 Andrew Nicolaedes, United
1995 Phillip D Coleridge-Smith, U
1996 Ermengildo A Enrici, Argent
1997 Prof Kevin G Burnand, Unit
1998 David Bergquist, Sweden
1999 David Robinson, United Sta
2000 Prof Sir Norman Browse, Un
2001 Prof Vaughn Ruckley, Scotla
2002 Prof Alfred Bollinger, Switze
2003 Prof Claudio Allegra, Italia
2004 Prof Eberhard Rabe, Deutchnated in its collection.5The inclusion of all of North and South America was
modeled after the broad envelope exemplified by the Amer-
ican College of Surgeons. In 2003, a South American
session was featured from the abstract submissions; in
2004, an international session. In addition to reporting the
results of several randomized clinical trials at the Society for
Vascular Surgery, AVF members have been prominently
involved in several educational symposia at other meetings,
including the Congress of the International Union for
Phlebology and the American College of Surgeons.
The Handbook of Venous Disorders: Guidelines of the
American Venous Forum6 has collated experience from
these meetings and is now in its second edition. A layman’s
version is available to the public on the AVF Website,
venous-info.com.7 A thrombosis risk assessment tool is
distributed for personal digital assistants at the annual
meeting. The CEAP classification for venous diseases,
which was developed at a consensus conference sponsored
by the AVF but is clearly an internationally based docu-
ment, has been adopted as the language of venous disease
worldwide.8,9 The outcomes committee has developed in-
struments for assessment of severity and disability, which
are becoming more widely used.10 Another AVF commit-
tee has again solicited an internationally based group to
consider revision of CEAP; its final report was prepared at
this meeting and published in the Journal of Vascular
Surgery (2004;40:1248-52).
Despite these accomplishments, we must still ask if we
have met the first goal—to improve the care of patients with
venous and lymphatic disorders (Fig 1). Have we convinc-
ingly demonstrated which interventions make a difference?
Do we know which interventions to recommend? When?
Which anti-thrombotic is best?11 Although there are excel-
lent, long-term observational data on vena cava filters, only
one randomized trial was identified in a recent systematic
review of the topic.11,12 We can estimate the prevalence of
thromboembolism from air travel, but cannot state that our
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of life, but cannot yet determine which interventions are
most effective in ameliorating this disability.14
As with so many other advances, CEAP has also offered
new challenges. Where do we classify the morbidly obese
individual with no anatomic evidence of venous disease? Do
they have a different form of chronic venous hyperten-
sion?15 What is the relationship between symptoms and
classifications of venous disease?14,16,17 Although several
studies have confirmed that the clinical classes correlate
with increasing severity, the relative risk of progression is
poorly understood. Is edema a precursor of lipodermato-
sclerosis? How commonly does lipodermatosclerosis lead
to ulceration?18 What is the role of the sensory abnormality
associated with chronic venous insufficiency (CVI)?19 Does
it confer a higher risk of recurrence? Of occurrence?
Is our knowledge incomplete? Can we make it better?
Will exploration, description, and understanding produce
improved management of chronic venous disorders? Like
any lawyer asking pointed questions in the pursuit of cross-
examination, we know the answer to these latter
questions—and it is yes.
KNOWLEDGE AND VEINS: THE RENAISSANCE
AND THE AVF
The geographic, cultural, and scientific world has
changed much since the 15th and 16th centuries, but the
exploration of the human form, description of the veins
(and arteries), and an understanding of their function,
Fig 2. Mid-15th century: the world as known to Europ
second century, but now the information was widely
world-view, Sebastian Münster, Geographia Universalis,bears a remarkable parallel to the status of venous knowl-edge today. We have explored the territory, identified the
anatomic components, and agreed upon the means to
describe the disease process. Greater understanding comes
each year, and new generations of investigators continue to
translate these findings into patient benefit.
Exploration. The discovery and exploration of the
New World coincided with important developments in the
identification and description of the anatomic parts that,
when pieced together with scientific understanding, would
constitute the critical physiologic concept of circulation of
the blood—knowledge that fostered improved manage-
ment of innumerable conditions. Concurrently, a renais-
sance was taking place in philosophy (characterized by an
emphasis on the power of reason), art (characterized by an
emphasis on realistic rendition of the human form), and
communication (characterized by printing with movable
type).
Before the exploration and discovery of America, the
world was a Eurocentric universe.20 The three continents
of Europe, Asia, and Africa retained the geography con-
ceived in the second century work of Claudius Ptolemy, as
illustrated in Fig 2. Modern 15th century technology, a
woodblock with moveable type, was used to print this map
on a press and it appeared in the Geographica Universalis
and Cosmographia of S. Munster.20 Southern Africa, its
seaward passage into the Southern Hemisphere, Australia,
Antarctica, and North and South America were still un-
known. Mid-15th century Europeans knew nothing of the
latter four continents, nor could they describe California or
as little changed from that described by Ptolemy in the
minated as a result of the printing press. Ptolemaic
. Private Collection.eans w
disseHawaii (Fig 2).
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Book III, De Humani Corporis Fabrica, Basle. Private Collection. B, Die Nüw Welt (The New World) is a
contemporary illustration of the two newly discovered continents; S Münster, Geographia Universalis, Basle.
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authoritative second century contemporary, Galen of Per-
gamun. Based largely on the influence conferred by centu-
ries of reliance in his works, students and doctors at the turn
of the 15th century believed that the arteries, veins, and
nerves were all vessels distributing different “spirits” to the
body. Blood was manufactured in the liver and distributed
by a process of ebb and flow along these hollow arteries and
veins. The animal spirit resided in the brain and was respon-
sible for animation through the nerves. The vital spirit or
heat was carried as air and blood in the arteries after
beginning in the trachea, which at that time carried the
name Aspera Arteria for “rough artery.” Galen had real-
ized that the arteries had to carry blood but postulated that
both blood and spirit were present in the smooth arteries.
The veins, which carried the blood to the body, were
considered more important than the arteries because there
were more of them and they were larger; they were usually
depicted in front of the artery.21,22
Description. The generation that matured in the years
following the discovery of the New World was primed to
question authoritative knowledge. Relevant to our state of
understanding today, physicians and, particularly, surgeons
began asking important questions about Galenic dogma
passed down from previous centuries.
Based upon direct personal experience, Andreas Vesa-
lius (1514-1564) explored and described the anatomy of
the body and reasoned that the authority of these ancient
texts should not be regarded above the actual findings
observed in human dissection. His detailed text De Hu-
mani Corporis Fabrica Libri Septem (Seven Books on the
Structure of the Human Body), published in 1543, was
remarkable for its integration of accurate, artistically ren-
dered illustrations coordinated with definitive text.21,23
This venerable text embodied the Renaissance values of
reason, artistry, and the new technology of printing. As an
example, the vein figure (Fig 3) lacks a surrounding enve-
lope of skin but conveyed structure from the images of the
veins themselves. However, both the arterial and venous
figures inaccurately depict the great vessels. The vein figure
demonstrated cephalic venous drainage to the external
jugular and equivalent-length innominate veins in the up-
per midline. The vein figure (depicted in Fig 3) and its
accompanying arterial figure (not illustrated) were attrib-
uted to the author himself (Fig 3).
Detailed musculoskeletal anatomic illustrations, now
highly prized for their intrinsic artistic value, were attrib-
uted to the studio of the Renaissance artist Titian. A con-
temporary surgeon, Ambroise Paré (1510-1590), applied
practical knowledge gained from personal treatment of
wounds and rapidly achieved fame for improved healing
with markedly less pain. In addition to advocating ligature
of bleeding vessels, he described varicose vein removal and
was aware of the value of compression bandaging. Reputed
as authorities in surgery, Vesalius and Paré consulted to-
gether on the management of a fatal jousting injury to King
Henry II of France.24Both individuals brought the same Renaissance spirit to
the advancement of medicine that Christofor Columbus
brought to the geophysical world. The geographic frame-
work of the world was forever altered by the exploration
and description of a new world that lay between Europe
and Asia (Fig 3)! The contemporary illustration depicts the
two new continents (Die Nüw Welt) that had been ex-
plored and described only 50 years previously. The dis-
torted outlines depicted were the first widely circulated
images of the New World and suggested the savage nature
of its inhabitants (“cannabali”) in the area that is now
Brazil. Efforts to find a Northwest Passage to the Orient
would continue for decades, fueled by a mistaken descrip-
tion of the Chesapeake as a northwest sea.
In conjunction with the accompanying maps of Africa,
Asia, and the world, these illustrations reflected Magellan’s
exploration of 1522, which proved that the globe could be
circumnavigated in the southern latitudes. Two continents
were still undiscovered, however. The map reflected prior
descriptions from Marco Polo and depicted the crude
knowledge derived from explorations contemporaneous
with Paré and Vesalius.
The advances of these scientists were achieved by the
application of empiric observation and public discourse
refuting the discrepancies of established ancient authority.
Despite these enormous contributions, the concept of an
“ebb and flow” was still the explanation for blood distribu-
tion in the publications of both of these eminent authori-
ties.21-23 We live in a world similar to theirs, wherein we
have now developed a new language for reporting (CEAP),
and available diagnostic tools (duplex scanning and pleth-
ysmography) have allowed for noninvasive dissection of the
anatomic and physiologic abnormalities of venous insuffi-
ciency and thrombosis, respectively. Like the explorers of
the 16th century, we expect that some observations will
lead to inaccurate conclusions and others will provide the
keys to critical new concepts.
Understanding the meaning and import of an observa-
tion may require the fresh insight of a new generation.
Then as now, we continue to rely on authority when new
hypotheses are either absent or ridiculed. At the close of the
16th century, the professor of anatomy and surgery at
Padua was a second-generation student of Vesalius. Hiero-
nymus Fabricius Aquapendente (1533-1620) was credited
with the description of valves in the lower extremity veins
(Fig 4). Although described in lectures as early as 1587,
publication of these findings in De Venarum Ostiolis (On
the Valves of the Veins) was delayed for almost two
decades.25 Like his predecessor Vesalius, he made an im-
portant discovery but did not complete the critical connec-
tion to understanding. He surmised that the valve pre-
vented retrograde venous flow, but he continued to
advance this explanation in the framework of the ebb and
flow of the spirits that Galen had described in the second
century.
Meanwhile, Mercator’s world map (Fig 4) provided
outlines of what appear to be the sixth and seventh conti-
nents; however, this reflected a common but misleading
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Volume 41, Number 2 Padberg 361Fig 4. A, 1587—the close of the 16th century. H Fabricius initially described the structure of venous valves De
Venarum Ostiolis (On the Valves of the Veins) in 1587. From Franklin KJ. Facsimile edition with introduction,
translation, and notes of De Venarum Ostioli (On the Valves of the Veins) 1603 of Heironymus Fabricius of
Aquapendente. Springfield (IL): Chas C. Thomas; 1933. Reprinted with permission. B, The contemporary double-
hemisphere world map is a reduced version of the original published by Gerhard and Rumold Mercator in The Atlas,
Geneva, 1587 (G. A. Magini, MD, Venice, 1596). Private Collection.
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with illustrations, typescript, and other postulated areas not
yet physically explored.26 The breadth of the North Amer-
ican continent is overestimated, but the concept of a
Northwest Passage had been dismissed by now.
Because we often become comfortable with existing
knowledge, we risk failure if we don’t recognize that some
of these illustrative descriptions are hypothetical. Widely
held beliefs often lead to delayed appreciation of actual fact
from direct observation, which were problems for both the
early cartographers, Columbus, and our next anatomist
from Padua, William Harvey.
Deduction and understanding. It is up to us, the
next generation of the AVF, to further utilize newly devel-
oped tools, such as magnetic resonance and computed
Fig 5. A, 1628: along with other observations, the contr
of the blood. William Harvey, De Motu Cordis, Frankfort
Sanguinis in Animalibus (Movement of the Heart an
translation with reproductions from the 1928 Tercent
Springfield (IL): Chas C. Thomas; 1930. Reprinted w
permanent colonization of the new world and perpetuat
Famous Parts of the World, London, 1626. Private Colletomography, to complete the description of the anatomyand venous pathophysiology and to develop and use new
instruments to measure the severity of disease from the
perspectives of both the treating physician and the patient.
It is our responsibility and opportunity to make the
connection between anatomic findings, to make the critical
deductions derived from newly developed diagnostic and
evaluative instruments, and to explain the physiologic con-
nections. Sixteenth century physicians deduced physiology
from macroscopic observations; microscopic anatomy pro-
vided understanding to the next generation. Newly devel-
oped molecular and functional advances now offer similar
opportunity to 21st century matriculants.
It was the third academic generation, in the person of
Englishman William Harvey, who synthesized the radical
new concept of circulation of blood in Exercitatio Ana-
venous flow by valves leads to the concept of a circulation
m Harvey W. Exercitatio Anatomica De Motu Cordis et
od in Animals), Frankfort, 1628. A modern English
Edition as presented by Chauncey D. Leake. 2nd ed.
ermission. B, A contemporaneous world-view reflects
tographic misconceptions. Speed, A Prospect of the most
.ol of
. Fro
d Blo
enial
ith p
es cartomicae de Motu Cordis et Sanguinalis in Animalibus (On
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(Fig 5).27 His conclusion was built on the foundation of his
teachers. He too matriculated in the anatomic theatre at
Padua, as had Fabricius and Vesalius before him.
Harvey’s hypothesis was developed while he conducted
a lucrative medical practice in London, which included two
royal clients. One of the several arguments supporting the
concept was the observation that the venous valve pre-
vented reflux of blood against gravity or pressure. Any
asthenic individual can demonstrate this by examining the
distended superficial veins on their forearm; in modern
venous surgery this is illustrated by the strip test for com-
petence after reconstruction of the venous valve. Other
evidence cited in support of this concept of a circulation was
to regard the heart as a pump and not just a muscle, the
absence of air in the arteries, and an estimate of the output
from the cardiac chamber.
He postulated that an individual with a 60 cm3 capacity
of the cardiac chamber and a rate of 65 beats per minute
would greatly exceed any volume that could be accommo-
dated by the ebb and flow theory. Harvey advanced these
assertions without the knowledge of capillary structure.
Despite logical and compelling reason, this seminal work,
De Motu Cordis, was only slowly accepted. Contemporary
with Harvey, his countryman John Speed published this
world-view (Fig 5) in 1626.28
Permanent colonization of North America was repre-
sented by the founding of Jamestown, Virginia in 1607 and
Plymouth Colony, Massachusetts Bay, in 1620. New Am-
sterdam was founded the same year, Boston in 1630, and
Williamsburg in 1633. The subsequent development of
these cities and the cultivation of tobacco in Virginia pre-
saged the future role of the new continent in the world
order. The map (Fig 5) illustrated 6 continents, continued
to overestimate the breadth of the North American conti-
nent, and portrayed California as an island; the latter erro-
neous concept was finally rectified 75 years later.
It was another 35 years after DeMotu Cordis before the
capillary circulation was visualized, a description of which
occurred after the development of a functional microscope.
It was Marcello Malphighi (1626-1694) who confirmed
the existence of a pulmonary capillary circulation in
1661.24 Despite the accumulating evidence, it took many
more years before the practical aspects of this discovery
supplanted the Galenic theories of the spirits. In the geo-
graphic realm, it would be well over 100 years before the
exploration and description of the Sandwich Islands
(Hawaii) in 1778, Australia in 1788, and Antarctica in
1820. Even today, with the rapidity of electronic commu-
nication, it may often require a generation for new knowl-
edge to be widely assimilated into clinical practice.29,30
Improving management. Eventually, Harvey’s views
were accepted and are now common knowledge among our
schoolchildren. The geophysical world is now visualized on
a grand scale from space; however, we have yet to unravel
the complex circulatory dynamics of the venous system.
Physiologic assessment of obstruction to venous flow re-
mains a major challenge; it remains difficult to define andaccurately diagnose obstruction. The relationship between
symptoms, physical findings, and objective abnormalities,
such as reflux and chronic thrombosis, has not always
correlated closely.14,16,17 The advantage of using a com-
prehensive classification that requires noninvasive data (ie,
basic CEAP) is the elimination of the inaccuracies inherent
in decisions based solely on clinical appearance.31 Perhaps
new hypotheses will arise from technological innovation,
and new clinical trials will be generated to confirm them.
Major trials contributing new practice algorithms are
certain to raise new questions, just as old beliefs will be
difficult to jettison. New anticoagulants are poised to rev-
olutionize the management of long-term therapy, just as
the beneficial effects of Coumadin therapy have been sol-
idly entrenched with multicenter, randomized prospective
trials. The benefits of physical training to ameliorate the
adverse effects of CVI on calf pump function were sug-
gested by a small, randomized, single-center trial.32 The
value of perforator ligation has been assessed by a Dutch
trial that suggested this modality had limited effects on the
outcomes measured.33
Accurate diagnostic classification with CEAP has raised
interesting new questions in familiar populations. Numer-
ous studies have confirmed that severe complications from
CVI increase with age.16-18 Morbidly obese patients fre-
quently develop severe, resistant, lower-extremity symp-
toms typical of CVI, but 62% have normal duplex exami-
nations; it is doubtful that this would all be due to occult
proximal venous occlusion.15 The response reported after
successful weight loss supports the concept that it is a
manifestation of a relative abdominal hypertension.
There is very little information on the probability of
progression from edema to pigmentation or induration;
similarly, there is little information on the likelihood that an
individual will progress from these more advanced states to
ulceration. Heit et al,18 in their 25-year population-based
study in Olmstead County, reported that 6.5% of patients
with a first-time, clinically defined diagnosis of “venous
stasis” progressed to ulceration in 5 years. The incidence of
ulceration in limbs with a post-thrombotic etiology is sim-
ilar and ranges from 3% to 15%.
In re-evaluating our own group of patients with severe
CVI, we identified a sensory neuropathy localized to the
gaiter distribution rather unlike the diffuse stocking distri-
bution seen with diabetes mellitus.19 Each of these devel-
opments has influenced the recommendations for manage-
ment of chronic venous disorders and offered guidance for
the direction of future investigation.
MISSION IMPOSSIBLE OR MISSION
ACCOMPLISHED?
The current call for increasing reliance on evidence-
based practice is again driven by reason. Reliance on au-
thority or expert opinion is a much easier path. However, as
demonstrated by our medieval forebears, the sovereign
knowledge base rapidly becomes stagnant and immutable if
it is allowed to reign without periodic reassessment. The
development of a new paradigm requires evidence that new
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evidence-based practice has inevitably led to a call for a
reassessment of the methods for reporting and investigat-
ing our experience. Although the exploration of new tech-
niques and methods are essential to integrate potential
advances into patient care, an accurate description of the
results are essential to understanding their benefit. It re-
mains a major challenge to effect meaningful change, how-
ever, even when based on good evidence.29,30
The prospective, randomized, controlled trial (RCT) is
considered the best design for the reduction of investigator
and random bias in subject allocation.34 The critical differ-
ence between an RCT and a historically controlled trial is
the acquisition of an unbiased control group.35 Well-
conducted trials have advanced the therapy of venous
thromboembolism at an astounding rate during the 20th
century. From Sevitt and Gallagher’s36 demonstration of
the benefit of anticoagulation for pulmonary embolism, the
management of both prophylaxis and treatment has been
steadily refined.11 The arrival in the near future of new oral
anticoagulant agents will make this therapy safer, more
widely applicable, and more patient friendly.
Defining the role of surgical management for venous
problems has proven more problematic.37,38 New proce-
dures are now characterized by a less-invasive methodol-
ogy, exemplified by the increasing range of endovascular
options. Because most manifestations of chronic venous
disorders are not life threatening, a reasonable point of
clinical equipoise between interventions for venous prob-
lems may be easier to establish than for other more invasive
procedures. Thus, it remains important to ethically design
trials that will establish the relative risks and benefits of
invasive therapies and to recruit individuals to participate in
them.38
Although the RCT is the best method for determining
cause and effect or evaluating differences from an interven-
tion, these trials are lengthy and expensive.34,35 To reduce
incomplete data reporting, most journals, including the
Journal of Vascular Surgery, now expect RCT reports to
adhere to the Consolidated Standards of Reporting Trials
(CONSORT) statement.39 However, subtle bias still exists
with this methodology, including publication bias or the
tendency to print research that is positive and reports a
strong effect; language bias (the positive results are more
likely to appear in English); and time-lag bias, in which
negative results are less likely to be rapidly published.40 In
situations where randomization is not ideal or reasonable,
observational studies or registries may be the best means of
collecting data for analysis.
A recently collated hierarchy for levels of evidence in
surgical trials addresses some of these special situations. For
example, level 1C is assigned to decisions with an “all or
none” outcome where the alternative treatment to surgical
intervention is likely to result in death (ie, ruptured aneu-
rysm or perforated viscus).37 Although pulmonary embo-
lism has a lethal implication, its mortal potential is substan-
tially less frequent than the incidence of venous thrombosis;
thus, to retain power while avoiding inordinately largerecruitment, most anticoagulant trials assess pulmonary
embolus as a component of an a priori endpoint of venous
thromboembolism.
Exploration and description of CVI has been greatly
enhanced by use of CEAP. Availability and reliability of
duplex analysis combined with noninvasive plethysmogra-
phy offers new methodology for description of the ana-
tomic and physiologic abnormalities associated with
CVI.8,9 Severity scores offer a method to record the physi-
cian’s assessment of the disease process, and new psycho-
metric instruments analyze the patients’ perspective with
questionnaires reflecting impact on their quality of life.10,14
Generic questionnaires provide information about outside
influences on the patients’ perception of their disability;
disease specific questionnaires assess the effect of the disease
on the individual’s quality of life.
New imaging modalities such as computed tomogra-
phy and magnetic resonance venography are just beginning
to be explored, and others will inevitably appear in the near
future. Molecular techniques offer to elucidate factors in
varicose disease, wound healing, and pharmacotherapy. It is
hoped that combining these methods will increase under-
standing of venous insufficiency and offer new directions
for improving patient care in venous and lymphatic dis-
eases.
By continuing to forge ahead with exploration of new
challenges, we modify our descriptions as new knowledge is
acquired. Understanding the balance of the risks and ben-
efits of new therapies leads to improvement in the care of
patients with venous and lymphatic diseases. By providing a
congenial venue for professional exchange on a high aca-
demic plane, the format of the AVF provides an important
opportunity to facilitate behavioral change in the form of
promoting, adopting, and disseminating value-based ad-
vances in the management of venous disorders. Thus, the
broadly brushed mission of our organization is integrally
related to advancing the treatment of chronic venous dis-
orders. It has truly been a pleasure to serve as your president
this year, and I look forward to a long and continued
relationship with this growing organization. Thank you.
Special thanks to Lois Densky-Wolff, Special Collec-
tions Librarian of the UMDNJ, George F. Smith Library,
for help with the illustrations.
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